Skip to main content
. 2019 Jan 1;2019:9726137. doi: 10.1155/2019/9726137

Table 3.

Effect of CE and ATOR on oxidative stress biomarkers of hyperlipidemic rats.

Parameters Control HFD ATOR CE ATOR + CE
MDA  
(nmol/g. tissue)
Liver 1.9±0.14a 3.58±0.14b 3.3±0.06b 2.87±0.08c 2.1±0.06a
Kidney 6.18±0.26a 9.02±0.27c 8.87±0.18c 7.72±0.51b 6.72±0.35a
Muscle 2.25±0.03a 3.52±0.19b 3.35±0.07b 2.15±0.09a 2.10±0.06a

GSH  
(mg/g. tissue)
Liver 7.23±0.23c 4.65±0.28a 5.40±0.31a 6.64±0.26b 7.10±0.18c
Kidney 15.00±0.58d 9.61±0.02a 10.23±0.22a 11.57±0.46b 13.50±0.76c
Muscle 10.85±0.34b 8.54±0.44a 9.55±0.02a 10.02±0.37b 10.26±0.10b

GST  
(U/g. tissue)
Liver 0.71±0.02c 0.51±0.02a 0.55±0.06a 0.66±0.03b 0.66±0.05c
Kidney 2.36±0.06c 1.17±0.07a 1.32±0.01a 1.93±0.04b 2.02±0.05b
Muscle 16.67±1.15c 10.50±0.67a 12.83±0.75a 14.67±0.42bc 15.17±0.31c

CAT  
(μmol/g tissue)
Liver 17.8±8.18b 10.8±1.66a 12.0±2.70a 15.6±4.24b 16.6±6.73b
Kidney 61.02±2.75b 32.93±1.62a 36.83±1.21a 57.68±1.81b 59.52±2.11b
Muscle 25.80±2.35c 10.07±1.44a 11.55±0.84a 16.53±0.86b 20.28±1.36b

Values are means ± SE (n = 6 per group). Each value not sharing a common letter superscript is significantly different (P <0.05).